MedPath

Non-invasive Monitoring of Newborns in the First Hours of Life for the Prevention of SUPC (Sudden Unexpected Postnatal Collapse): Interventional Study With Medical Device

Not Applicable
Not yet recruiting
Conditions
Sudden Unexpected Postnatal Collapse -SUPC
Registration Number
NCT07213401
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

The application of non-invasive monitoring via a wearable device in newborns during the first 48-72 hours of life could enable early recognition and timely management of episodes that may result in SUPC, thereby improving clinical practice.

Detailed Description

SUPC is a rare event, with maximum incidence in the first 2 hours of life of the newborn. Despite the rarity of events, the consequences can be dramatic, with a high risk of death and severe neurological disabilities. To date, prevention of events is based on serial clinical monitoring of newborns during skin-to-skin contact.

Some non-invasive monitoring systems integrated into wearable textiles have proven to be reliable and are well tolerated by newborns, families, and healthcare personnel.

The application of non-invasive monitoring via a wearable device in newborns during the first 48-72 hours of life could enable early recognition and timely management of episodes that may result in SUPC, thereby improving clinical practice.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Gestational age ³ 35 weeks
  • Apgar score at 5 minutes ³ 8
  • Acquisition of written informed consent from the parent/guardian
Exclusion Criteria
  • Major congenital malformations
  • Family history of silver allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
prodromal events of SUPC72 hours

Measure how many prodromal events of SUPC (bradycardia, bradypnea, apnea) are detected with the ComfTech HOWDY BABY device (ComfTech S.r.l.), outside the times scheduled for clinical monitoring in the first 72 hours of life of newborns.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Irccs Aoubo

🇮🇹

Bologna, BO, Italy

Irccs Aoubo
🇮🇹Bologna, BO, Italy
Luigi Tommaso Corvaglia, MD
Contact
0512143691
luigi.corvaglia@unibo.it

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.